Stay updated with breaking news from Nasdaq Cnce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Concert Pharmaceuticals (NASDAQ:CNCE – Get Rating) in a report published on Wednesday. The firm issued a sell rating on the biotechnology company’s stock. Several other research firms also recently weighed in on CNCE. JMP Securities downgraded Concert Pharmaceuticals to a market perform rating in a research note on Thursday, […]
Research analysts at StockNews.com began coverage on shares of Concert Pharmaceuticals (NASDAQ:CNCE – Get Rating) in a research note issued to investors on Wednesday. The brokerage set a “sell” rating on the biotechnology company’s stock. CNCE has been the topic of a number of other reports. Truist Financial cut Concert Pharmaceuticals from a “buy” rating […]
StockNews.com assumed coverage on shares of Concert Pharmaceuticals (NASDAQ:CNCE – Get Rating) in a report issued on Wednesday. The brokerage issued a sell rating on the biotechnology company’s stock. A number of other research analysts also recently weighed in on the stock. JMP Securities downgraded shares of Concert Pharmaceuticals to a market perform rating in […]
StockNews.com initiated coverage on shares of Concert Pharmaceuticals (NASDAQ:CNCE – Get Rating) in a report published on Tuesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Several other equities analysts also recently weighed in on the company. JMP Securities downgraded Concert Pharmaceuticals to a market perform rating in a research report […]
Concert Pharmaceuticals (NASDAQ:CNCE – Get Rating) issued its quarterly earnings results on Thursday. The biotechnology company reported ($1.03) earnings per share for the quarter, missing the consensus estimate of ($0.93) by ($0.10), MarketWatch Earnings reports. Concert Pharmaceuticals had a negative return on equity of 69.59% and a negative net margin of 245.72%. During the same […]